Dreyfus/The Boston Company Small Cap Growth Fund Class I (SSETX)

37.87
Net Asset Value
+0.13%
1 Day
+4.10%
Year-to-Date
Overall Morningstar Rating
Small growth
Style or Category
No Load
Sales Expenses
1.15%
Expense Ratio
Below Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term growth of capital. The fund normally invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of small-cap U.S. companies. The adviser currently considers small-cap companies to be those with total market capitalizations that are equal to or less than the total market capitalization of the largest company included in the Russell 2000 ® Growth Index, the fund's benchmark index. The fund's investment strategy may lead it to emphasize certain sectors, such as technology, health care, business services and communications.

Performance

1 month+4.53% 3 years+16.82%
3 months+6.93% 5 years+15.42%
1 year+1.38% Since inception+10.55%
Data through --

Peer Comparisonvs. Small growth

 SSETXCategory
Performance 5-yr return+15.42%+15.53%
Expense ratio1.15%1.40%
Risk 5 year sharpe ratio0.980.95
Net assets$28.7M$805.4M
Average market cap$1.4B$2.7B
Average P/E28.926.0
Portfolio turnover138%138%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyDreyfus
Fund manager & tenureTodd Wakefield / 1 Years
Minimal initial investment$1,000.00
Minimum IRA investment$1,000.00

Holdings

U.S. stock89.17%
International stock9.61%
Cash1.22%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 17.35%
Industrial materials 11.69%
Hardware 10.82%
Consumer service 10.21%
Financial service 7.95%
Top 10 Holdings
Portfolio weighting
WX Wuxi Pharmatech Cayman Inc2.31%
WSO Watsco Inc2.11%
PCRX Pacira Pharmaceuticals Inc1.92%
CLDX Celldex Therapeutics Inc1.72%
SONS Sonus Networks Inc1.71%
ANAC Anacor Pharmaceuticals Inc1.69%
MXL MaxLinear Inc1.65%
MENT Mentor Graphics Corp1.65%
LOGM LogMeIn Inc1.64%
KYTH KYTHERA Biopharmaceuticals Inc1.62%

To view my watchlist

Not a member yet?

Sign up now for a free account